Busulfan 6 mg/mL (Busulfan INJECTION) 6 mg/mL

Busulfan 6 mg/mL is an injectable medication used for specific medical conditions. This intravenous solution is available in single-dose vials, providing a convenient option for targeted therapy.

Strength

6 mg/mL

Pack Size

8 VIAL, SINGLE-DOSE in 1 CARTON (16729-351-92) / 10 mL in 1 VIAL, SINGLE-DOSE (16729-351-03)

Manufacturer / TM Owner

Accord Healthcare, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Busulfan 6 mg/mL is primarily used in the management of certain types of cancer. It works by interfering with the growth of cancer cells, making it a critical component in some chemotherapy regimens. Patients often wonder, 'What is Busulfan used for?' This medication is typically prescribed for conditions that require precise and potent treatment.

Side Effects

Common effects of Busulfan 6 mg/mL may include nausea, vomiting, and fatigue. Some patients might experience hair loss or changes in blood cell counts. These effects can vary widely depending on individual factors and the specific treatment plan.

Precautions & Warnings

Busulfan 6 mg/mL should be handled with care, as it is a potent medication. It is important to follow the advice of a healthcare provider regarding administration and monitoring. Patients should be aware of potential side effects and report any unusual symptoms promptly.

Avoid Interactions

Busulfan 6 mg/mL may interact with other medications, including those that affect the liver or bone marrow. It is crucial to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness or safety of Busulfan.

References

Frequently Asked Questions

Busulfan 6 mg/mL is used in the treatment of certain types of cancer, particularly in chemotherapy regimens.

Busulfan 6 mg/mL is administered intravenously, typically in a clinical setting under the supervision of a healthcare provider.

Common side effects may include nausea, vomiting, fatigue, and hair loss. Individual experiences can vary.

Busulfan 6 mg/mL may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Precautions include following the healthcare provider's instructions closely and monitoring for any unusual symptoms.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.